Active	Status	Sponsor type	Region	Phase	Filter
6 Active 26 Inactive 32 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

6 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
recombinant parainfluenza virus 5 vaccine (BLB101) / CyanVac LLC, The University of Iowa
NCT05736835: A Phase 2 Trial of the Immunogenicity and Safety of CVXGA Intranasal COVID Vaccine in Healthy Adults	Active, not recruiting	2	227	US	CVXGA, PIV5-SARS CoV-2	CyanVac LLC	COVID-19	07/24	10/24
CVXGA1-001, NCT04954287: Phase 1 Study of Intranasal PIV5 COVID-19 Vaccine Expressing SARS-CoV-2 Spike Protein in Healthy Adults and Adolescents	Completed	1	72	US	CVXGA1 low dose, PIV5-SARS CoV-2 vaccine, CVXGA1 high dose	CyanVac LLC	Covid19	06/23	06/23
selenomethionine (SLM) / Holden Comprehensive Cancer Center, The University of Iowa
NCT00935038: Selenomethionine in Reducing Mucositis in Patients With Locally Advanced Head and Neck Cancer Receiving Cisplatin and Radiation Therapy	Active, not recruiting	2	18	US, RoW	selenomethionine, placebo	Roswell Park Cancer Institute	Chemotherapeutic Agent Toxicity, Head and Neck Cancer, Mucositis, Radiation Toxicity, Xerostomia	04/12
NCT05363631: Seleno-L Methionine (SLM)-Axitinib-Pembrolizumab	Recruiting	1/2	55	US	Selenomethionine (SLM), Axitinib, Pembrolizumab	Bilal G. Rahim, University of Iowa	Clear Cell Renal Cell Carcinoma, Clear Cell Renal Cell Carcinoma Metastatic	12/26	12/26
OSCAR, NCT04952129: Optimal Selenium for Bowel Polyps	Active, not recruiting	1	56	RoW	Selenomethionine, L-selenomethionine, Methylselenocysteine, Se-methyl-selenocysteine	University of Auckland, New Zealand, Cancer Trials New Zealand, Counties Manukau Health, Waikato Hospital	Colorectal Adenoma	06/24	08/24
NCT02535533: SLM + Axitinib for Clear Cell RCC	Active, not recruiting	1	46	US	Selenomethionine (SLM), Axitinib	Bilal G. Rahim, Pfizer	Advanced Metastatic Clear Cell Renal Cell Carcinoma (CCRCC)	08/23	05/26